RCM
SRDX

Riverhead Capital Management’s Surmodics SRDX Stock Holding History

Riverhead Capital Management’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$69K Buy
1,500
+500
+50% +$21.8K ﹤0.01% 1401
2019
Q2 		$43K Buy
1,000
+400
+67% +$16.9K ﹤0.01% 1461
2019
Q1 		$26K Buy
+600
New +$30.6K ﹤0.01% 1464

Other funds holding SRDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Riverhead Capital Management's SRDX Position: Q3 2019 in Review

Riverhead Capital Management increased its Surmodics (SRDX) stake by 50% in Q3 2019, buying an estimated $21.8K and bringing the position to 1,500 shares worth $69K. The position accounts for ﹤0.01% of the portfolio, ranked #1401.

Riverhead Capital Management first reported a position in SRDX in Q1 2019 and has held it in 3 quarters since. 146 funds tracked by Wall St. Rank hold SRDX as of Q3 2019.

  • Riverhead Capital Management held 1,500 shares of Surmodics worth $69K as of Q3 2019.
  • Riverhead Capital Management bought 500 Surmodics shares in Q3 2019, an estimated $21.8K.
  • Surmodics made up ﹤0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #1401 holding.
  • Riverhead Capital Management first reported a position in Surmodics in Q1 2019 and has held it in 3 quarters since.
  • 146 funds tracked by Wall St. Rank held Surmodics as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.